![](https://2c717466dc25cd7041c9-8eeda6a8ca964cf210ed223dbc947813.ssl.cf2.rackcdn.com/1346690-516366538-cellectis-logo-png-100x40.png)
Cellectis Provides Business Update and Reports Financial Results for Third Quarter and First Nine Months 2020
Sponsored program at ASH 2020 – Oral presentation of initial data for BALLI-01 clinical trial evaluating UCART22 product candidate in adult patients with R/R B-cell Acute Lymphoblastic Leukemia (B-ALL) Partnered programs at ASH 2020 – UNIVERSAL abstract …